Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

VELETRI for Portopulmonary hypertension: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 8 adverse event reports in the FDA FAERS database where VELETRI was used for Portopulmonary hypertension.

Most Reported Side Effects for VELETRI

Side Effect Reports % Deaths Hosp.
Dyspnoea 59 17.7% 25 52
Death 48 14.4% 48 24
Nausea 36 10.8% 12 26
Pulmonary arterial hypertension 34 10.2% 17 30
Pneumonia 33 9.9% 7 33
Headache 30 9.0% 8 20
Vomiting 27 8.1% 9 21
Diarrhoea 26 7.8% 10 22
Pain in jaw 23 6.9% 6 15
Right ventricular failure 23 6.9% 20 18
Fluid retention 21 6.3% 12 19
Condition aggravated 18 5.4% 8 14
Dizziness 18 5.4% 7 16
Flushing 18 5.4% 4 12
Malaise 17 5.1% 9 13

Other Indications for VELETRI

Pulmonary arterial hypertension (235) Cor pulmonale chronic (43) Product used for unknown indication (17) Pulmonary hypertension (14)

Other Drugs Used for Portopulmonary hypertension

AMBRISENTAN (428) MACITENTAN (153) EPOPROSTENOL (52) TREPROSTINIL (46) SELEXIPAG (35) LETAIRIS (29) SILDENAFIL (29) BOSENTAN (26) TADALAFIL (16) BOSENTAN\BOSENTAN (10)

Related Pages

VELETRI Full Profile All Portopulmonary hypertension Drugs VELETRI Demographics VELETRI Timeline